FAQs about Health » Chronic Disease Management » Diabetes
News about Health » Chronic Disease Management » Diabetes
Novo’s CagriSema tops semaglutide in ph. 3 diabetes study - Fierce Biotech [Visit Site | Read More]
Novo Nordisk's next-gen obesity drug outperforms Wegovy in late-stage diabetes trial - Reuters [Visit Site | Read More]
Novo combination obesity shot meets goal in diabetes trial - BioPharma Dive [Visit Site | Read More]
New review highlights growing evidence that diabetes drug metformin can prevent long COVID - CIDRAP [Visit Site | Read More]
Diabetes medication prescribed to millions can help protect against disease which has left 600,000 struggling with blindness, study finds - Daily Mail [Visit Site | Read More]
Massive Global Study Rewrites the Biology of Type 2 Diabetes - SciTechDaily [Visit Site | Read More]